Investment by Maven Capital Partners in BioAscent Discovery

Maven Capital Partners (“Maven”) completed a £1.6m investment in BioAscent Discovery Ltd, an integrated drug discovery services business. The funding will enable the company to expand its service offering, adding complementary chemistry and biology services and capitalise on the growing trend of outsourcing drug discovery activities.

BDO provided financial due diligence in support of Maven's investment.